ATE97810T1 - Injizierbare cephalosporinpraeparate und ihre anwendung. - Google Patents

Injizierbare cephalosporinpraeparate und ihre anwendung.

Info

Publication number
ATE97810T1
ATE97810T1 AT90118682T AT90118682T ATE97810T1 AT E97810 T1 ATE97810 T1 AT E97810T1 AT 90118682 T AT90118682 T AT 90118682T AT 90118682 T AT90118682 T AT 90118682T AT E97810 T1 ATE97810 T1 AT E97810T1
Authority
AT
Austria
Prior art keywords
salt
preparation
lactose
medicament
pharmaceutically acceptable
Prior art date
Application number
AT90118682T
Other languages
English (en)
Inventor
Yasuo Ishibashi
Isamu Hasegawa
Masanori Kayano
Ryoichi Machida
Masahiro Kawahara
Sumio Watanabe
Original Assignee
Eisai Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai Co Ltd filed Critical Eisai Co Ltd
Application granted granted Critical
Publication of ATE97810T1 publication Critical patent/ATE97810T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Medicinal Preparation (AREA)
AT90118682T 1989-09-30 1990-09-28 Injizierbare cephalosporinpraeparate und ihre anwendung. ATE97810T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP25378289 1989-09-30
EP90118682A EP0421297B1 (de) 1989-09-30 1990-09-28 Injizierbare Cephalosporinpräparate und ihre Anwendung

Publications (1)

Publication Number Publication Date
ATE97810T1 true ATE97810T1 (de) 1993-12-15

Family

ID=17256076

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90118682T ATE97810T1 (de) 1989-09-30 1990-09-28 Injizierbare cephalosporinpraeparate und ihre anwendung.

Country Status (10)

Country Link
US (1) US5254545A (de)
EP (1) EP0421297B1 (de)
JP (1) JP3129428B2 (de)
KR (1) KR950013760B1 (de)
CN (1) CN1046632C (de)
AT (1) ATE97810T1 (de)
CA (1) CA2026516C (de)
DE (1) DE69004921T2 (de)
DK (1) DK0421297T3 (de)
ES (1) ES2059947T3 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0840907A (ja) 1994-08-03 1996-02-13 Meiji Seika Kaisha Ltd セファロスポリン注射剤
US5721229A (en) * 1995-12-26 1998-02-24 Veterinary Pharmacy Corporation Soluble forms of cephalosporins and treatment of animals
UA80095C2 (en) * 2001-07-20 2007-08-27 Lilly Co Eli 2 methyl-thieno-benzodiazepine lyophilized formulation and method for the preparation thereof
EP1656930A1 (de) * 2004-11-10 2006-05-17 Basilea Pharmaceutica AG Stabilisierte gefriergetrocknete Formulierung für Cephalosporinderivate
AU2008302201A1 (en) * 2007-09-21 2009-03-26 Astrazeneca Ab Soluble dosage forms containing cephem derivatives suitable for parenteral administration
CN103860484B (zh) * 2012-12-18 2016-08-24 四川科伦药业股份有限公司 注射用头孢妥仑钠冻干制剂及其制备方法
CN103860563B (zh) * 2012-12-18 2016-07-06 四川科伦药业股份有限公司 含头孢妥仑钠的药物组合物
WO2014158952A1 (en) 2013-03-13 2014-10-02 Theravance, Inc. Hydrochloride salts of an antibiotic compound
KR102329764B1 (ko) * 2013-03-15 2021-11-23 머크 샤프 앤드 돔 코포레이션 세프톨로잔 항균성 조성물
US8906898B1 (en) * 2013-09-27 2014-12-09 Calixa Therapeutics, Inc. Solid forms of ceftolozane
WO2016035846A1 (ja) * 2014-09-04 2016-03-10 塩野義製薬株式会社 カテコール基を有するセファロスポリン類を含有する製剤

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2690009B2 (ja) * 1986-07-10 1997-12-10 エーザイ 株式会社 セフアロスポリン注射剤
IL84128A (en) * 1986-10-13 1992-12-01 Eisai Co Ltd 3-propenylcephem derivatives, their preparation and pharmaceutical compositions containing them
EP0612751A3 (en) * 1988-03-16 1994-09-21 Eisai Co Ltd Compounds for the preparation of cephem derivatives.

Also Published As

Publication number Publication date
DE69004921T2 (de) 1994-05-05
CN1050501A (zh) 1991-04-10
EP0421297A3 (en) 1991-06-12
US5254545A (en) 1993-10-19
JPH03173822A (ja) 1991-07-29
EP0421297B1 (de) 1993-12-01
KR910005871A (ko) 1991-04-27
ES2059947T3 (es) 1994-11-16
KR950013760B1 (ko) 1995-11-15
EP0421297A2 (de) 1991-04-10
DE69004921D1 (de) 1994-01-13
DK0421297T3 (da) 1994-01-17
JP3129428B2 (ja) 2001-01-29
CA2026516A1 (en) 1991-03-31
CN1046632C (zh) 1999-11-24
CA2026516C (en) 1998-02-17

Similar Documents

Publication Publication Date Title
AU617918B2 (en) 2-aminopyrimidinone derivatives
CA2039056A1 (en) 3,5-di-tertiarybutyl-4-hydroxyphenylmethylene derivatives of 2-substituted thiazolidinones, oxazolidinones, and imidazolidinones as antiinflammatory agents
NO932745L (no) Triazolyltiometyltiocefalosporinhydroklorid, dets krystalliske hydrat samt fremgangsmaate for fremstilling
GB9026776D0 (en) Amino acid derivatives
BR9503536A (pt) Composto processo para sua preparação seu uso e composição farmacêutica
DK491489A (da) Imidazolinderivater samt fremgangsmaade til fremstilling deraf
DE69004921D1 (de) Injizierbare Cephalosporinpräparate und ihre Anwendung.
HU900063D0 (en) Process for preparation of new 2-amino-pyrimidinone-derivatives
HUT58709A (en) Process for producing n-aryl-piperazin-acetamide derivatives and pharmaceutical compositions containing them
AU3917189A (en) Antipsychotic 3-piperazinyl benzazole, benzisoxazole and benzisothiazole derivatives
PH25532A (en) Novel n-(4-piperidinyl) bicyclic condensed 2-imidazolamine derivatives, pharm,aceutical composition containing said compound, method of use thereof
FI893426A0 (fi) Analogiamenetelmä terapeuttisesti käyttökelpoisten BU-3608-johdannaisten ja niiden suolojen valmistamiseksi
ES2045067T3 (es) Procedimiento para preparar nuevos compuestos de tiazol.
CY1870A (en) Derivatives of penciclovir for the treatment of hepatitis-B infections
GB8706662D0 (en) Anti-arrhythmia agents
DK424888A (da) Naphthothiazepinderivater, fremgangsmaade til fremstilling deraf samt farmaceutiske praeparater indeholdende saadanne derivater
EP0452809A3 (en) A therapeutic agent for dysuria comprising alpha-phenyl-alpha-pyridylalkanoic acid derivatives
JO1229B1 (en) Penicillin derivatives

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee